Vascular Access Devices Market Analysis, Size, Trends | Europe | 2017-2023 | MedSuite (Includes 11 Reports)

Vascular Access Devices Market Analysis, Size, Trends | Europe | 2017-2023 | MedSuite (Includes 11 Reports)

0

The full report suite on the European market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), dialysis catheters, manufactured catheter securement devices (MCSDs) and syringes and needles. Vascular access devices are used for gaining access to a patient’s bloodstream via the veins. They can deliver a wide range of treatments, including fluid infusion, blood draws, parenteral nutrition, antibiotics, chemotherapy and dialysis. The duration of treatment lasts anywhere from hours to years, depending on the type of vascular access device used and the type of medication that is being infused.

  • Year: 2017
  • Scope: 2013-2023
  • Region: Europe
  • Published Date: 10/1/2016
  • Pages: 890
  • Type: MedSuite

The syringe and needle market accounted for over 60% of the total vascular access device market in 2016. As such, trends affecting the syringe and needle market have a substantial effect on the total market. There are two main trends affecting the syringe and needle market: the conversion to safety devices and the conversion to insulin pen needles. There will also be an increase in growth throughout the port needle, central venous catheter (CVC) and peripherally inserted central catheter (PICC) markets. The European market for MCSDs is expected to be the fastest growing segment in the total European vascular access market over the forecast period. This is through the result of catheter-related infections being no longer reimbursed. This report includes an analysis of other factors and trends that have positively and negatively impacted the market.

Europe-wide legislation encouraging the use of safety devices implemented in 2013 and early 2014 have been transposed in all countries included in this report. In addition, regions in Europe have passed their own laws to promote the use of safety devices such as syringes and needles in the workplace. Safety products carry a significant price premium compared to conventional products; the higher ASPs of these safety devices have increased the value of the market, and ongoing conversion is expected to boost future growth. While the conversion to the use of safety needles and PIVCs is taking place in Europe following the introduction of the directive by the Council of the European Union, lack of enforcement by local authorities will hinder the conversion to safety devices. In 2016, it was estimated that approximately 90% of patients who were hospitalized in the Western European region received vascular access treatment during their stay. The ability to infuse medications or fluids into a patient’s bloodstream is indispensable to modern medicine. Vascular access devices include peripheral intravenous catheters (PIVCs), peripherally inserted central catheters (PICCs), central venous catheters (CVCs), implantable ports, Huber needles, dialysis catheters, manufactured catheter securement devices and syringes and needles. The European market for vascular access devices and accessories includes Germany, France, Italy, the United Kingdom, Spain, Benelux (the Netherlands, Belgium and Luxembourg), Scandinavia (Sweden, Norway, Denmark and Finland), Portugal, Austria and Switzerland.

While this report suite contains all European vascular access device data, each of the markets are also available as standalone MedCore reports. This allows you to get access to only the vascular access market research that you need. You can view all these included reports and segmentation here:

  • Market Overview for Vascular Access Devices – MedView – Overview chapter on the European market for vascular access devices.  It provides a snapshot of what trends, drivers and limiters are affecting each market segment. The chapter also includes a brief analysis of the competitive market share.
  • Product Portfolio for Vascular Access Devices – Medfolio – Covering all segmentation within this vascular access suite we include insight on all available products in each market, any recalls and clinical trials.
  • Procedure Numbers for Vascular Access Devices – MedPro – Provides available procedure numbers used for vascular access devices
  • Market Report for Implantable Ports – MedCore – In-depth analysis of the Implantable Ports market. The chapter covers conventional implantable ports and power-injectable implatable ports, as well as, providing units sold analysis.
  • Market Report for Port Needles – MedCore – In-depth analysis of the Port Needles market. Chapter provides analysis and forecast of both safety port needle and power-injectable port needle markets.
  • Market Report for Central Venous Catheters – MedCore – In-depth analysis of the Central Venous Catheter market. Chapter segments the CVC market into acute and chronic. Acute CVCs are intended to use for a few days, while chronic CVCs are used for approximately six months.
  • Market Report for Peripherally Inserted Central Catheters – MedCore – In-depth analysis of the Peripherally Inserted Central Catheter market. The chapter segments the devices to conventional peripherally inserted central catheters and power-injectable peripherally inserted central catheters.
  • Market Report for Peripheral Intravenous Catheters – MedCore – In-depth analysis of the Intravenous Catheter market. Covers segmentation into the Conventional Peripheral Intravenous Catheter market, Safety Peripheral Intravenous Catheter market and the Midline Catheter market.
  • Market Report for Dialysis Catheters – MedCore – In-depth analysis of the Dialysis Catheter market. Also includes coverage and analysis of the Acute Hemodialysis Catheter market, the Chronic Hemodialysis Catheter market and the Peritoneal Dialysis Catheter market.
  • Market Report for Catheter Securement Devices – MedCore – In-depth analysis of the Catheter Securement device market that includes units sold by country, drivers and limiters affecting the market and competitive market share analysis of the companies involved in the market.
  • Market Report for Syringes and Needles – MedCore – In-depth analysis of the Syringe and Needles market that covers units sold by country, drivers and limiters affecting the market and competitive market share analysis of the companies involved in the market.

Vascular Access Devices Market Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2023, and Historical Data to 2013
  • Market Drivers & Limiters for Each Device Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors
  • Related Press Releases from Top Competitors

Vascular Access Companies Analyzed

With such a large market, the European vascular access device and accessories market carry a diverse amount of companies involved. Becton Dickinson earned the top spot in the market due to its high PIVC and syringe and needle sales in 2016. B. Braun was the second leading competitor in the market and have been growing substantially over the years due to its diverse product portfolio that crosses multiple therapeutic areas.

Companies researched in this report for Europe include Vygon, Smiths Medical, Teleflex, Medcomp, Baxter International, Centurion Medical Products, Terumo, TIDI Products, Novico, Ambu Inc, Access Scientific, 3M, Artsana, Perouse Medical and various others.

EUROPEAN VASCULAR ACCESS DEVICE AND ACCESSORIES MARKET OVERVIEW 278
4.1 INTRODUCTION 278
4.2 CURRENCY EXCHANGE RATE 279
4.3 MARKET OVERVIEW 280
4.4 TREND ANALYSIS 286
4.5 DRIVERS AND LIMITERS 289
4.5.1 Market Drivers 289
4.5.2 Market Limiters 291
4.6 COMPETITIVE MARKET SHARE ANALYSIS 293
4.7 COMPANY PROFILES 297
4.7.1 AngioDynamics 297
4.7.2 B. Braun 298
4.7.3 Becton Dickinson 298
4.7.4 C. R. Bard 299
4.7.5 Medcomp 300
4.7.6 Medtronic 300
4.7.7 Smiths Medical 302
4.7.8 Teleflex 303
4.7.9 Terumo 304
4.8 SWOT ANALYSIS 305
4.8.1 B. Braun 305
4.8.2 Becton Dickinson 306
4.8.3 C.R. Bard 307
4.8.4 Medtronic 308
4.8.5 Smiths Medical 309
4.8.6 Teleflex 310
4.8.7 Terumo 311
4.9 MERGERS AND ACQUISITIONS 312
COUNTRY PROFILES 317
5.1 INTRODUCTION 317
5.1.1 Population 317
5.1.2 GDP Per Capita 317
5.1.3 Price Index 317
5.2 GERMANY 318
5.3 FRANCE 319
5.4 UNITED KINGDOM 320
5.5 ITALY 321
5.6 SPAIN 322
5.7 BENELUX 323
5.8 SCANDINAVIA 324
5.9 AUSTRIA 325
5.10 SWITZERLAND 326
5.11 PORTUGAL 327
PROCEDURE NUMBERS 328
6.1 TOTAL VASCULAR ACCESS PROCEDURES 328
6.2 IMPLANTABLE PORT PROCEDURES 331
6.3 PORT NEEDLE PROCEDURES 334
6.4 CVC PROCEDURES 337
6.5 PICC PROCEDURES 340
6.6 PIVC PROCEDURES 343
6.7 DIALYSIS CATHETER PROCEDURES 346
6.8 ULTRASOUND VASCULAR ACCESS PROCEDURES 353
IMPLANTABLE PORT MARKET 355
7.1 INTRODUCTION 355
7.1.1 Implantable Port Patients 355
7.1.2 Port Implantation Procedures 356
7.1.3 Port Infusion 356
7.1.4 Port Maintenance 357
7.1.5 Power Ports 357
7.2 MARKET OVERVIEW 358
7.3 MARKET ANALYSIS AND FORECAST 362
7.3.1 Total Implantable Port Market 362
7.3.2 Conventional Implantable Port Market 370
7.3.2.1 Single-Lumen Conventional Implantable Port Market 377
7.3.2.2 Double-Lumen Conventional Implantable Port Market 379
7.3.3 Power-Injectable Implantable Port Market 381
7.3.3.1 Single-Lumen Power-Injectable Implantable Port Market 388
7.3.3.2 Double-Lumen Power-Injectable Implantable Port Market 390
7.4 DRIVERS AND LIMITERS 392
7.4.1 Market Drivers 392
7.4.2 Market Limiters 393
7.5 COMPETITIVE MARKET SHARE ANALYSIS 396
PORT NEEDLE MARKET 401
8.1 INTRODUCTION 401
8.1.1 Safety Port Needles 401
8.1.2 Power-Injectable Port Needles 402
8.2 MARKET OVERVIEW 403
8.3 MARKET ANALYSIS AND FORECAST 407
8.3.1 Total Port Needle Market 407
8.3.2 Conventional Port Needle Market 415
8.3.3 Safety Port Needle Market 422
8.3.3.1 Power-Injectable Safety Port Needle Market 429
8.3.3.2 Non-Power-Injectable Safety Port Needle Market 436
8.4 DRIVERS AND LIMITERS 443
8.4.1 Market Drivers 443
8.4.2 Market Limiters 443
8.5 COMPETITIVE MARKET SHARE ANALYSIS 445
CENTRAL VENOUS CATHETER MARKET 449
9.1 INTRODUCTION 449
9.1.1 CVC Procedures 450
9.1.2 CVC Kits 450
9.1.3 CVC Market Segments 451
9.1.4 Antimicrobial CVCs 451
9.1.5 Multi-Lumen CVCs 452
9.1.6 Chronic CVCs 452
9.2 UNIT ANALYSIS 454
9.2.1.1 Acute CVC Units Sold by Patient Type 454
9.3 MARKET OVERVIEW 456
9.4 MARKET ANALYSIS AND FORECAST 460
9.4.1 Total Central Venous Catheter Market 460
9.4.2 Total Acute Central Venous Catheter Market 468
9.4.2.1 Conventional Acute Central Venous Catheter Market 475
9.4.2.2 Antimicrobial Acute Central Venous Catheter Market 482
9.4.3 Chronic Central Venous Catheter Market 489
9.5 DRIVERS AND LIMITERS 496
9.5.1 Market Drivers 496
9.5.2 Market Limiters 497
9.6 COMPETITIVE MARKET SHARE ANALYSIS 499
PERIPHERALLY INSERTED CENTRAL CATHETER MARKET 508
10.1 INTRODUCTION 508
10.1.1 PICC Placement 508
10.1.2 Catheter Material 509
10.1.3 Power-Injectable PICCs 510
10.2 UNIT ANALYSIS 511
10.2.1.1 Peripherally Inserted Central Catheter Units Sold by Lumen Number 511
10.3 MARKET OVERVIEW 513
10.4 MARKET ANALYSIS AND FORECAST 517
10.4.1 Total Peripherally Inserted Central Catheter Market 517
10.4.2 Conventional Peripherally Inserted Central Catheter Market 525
10.4.3 Power-Injectable Peripherally Inserted Central Catheter Market 532
10.5 DRIVERS AND LIMITERS 539
10.5.1 Market Drivers 539
10.5.2 Market Limiters 540
10.6 COMPETITIVE MARKET SHARE ANALYSIS 543
PERIPHERAL INTRAVENOUS CATHETER MARKET 548
11.1 INTRODUCTION 548
11.1.1 Safety PIVCs 549
11.1.1.1 Blood Control Safety PIVCs 549
11.1.1.2 Non-Blood Control Safety PIVCs 549
11.1.1.2.1 Active Safety PIVCs 550
11.1.1.2.2 Passive Safety PIVCs 550
11.2 UNIT ANALYSIS 551
11.2.1.1 Blood Control Safety Peripheral Intravenous Catheter Units Sold by Blood Control Mechanism 551
11.3 MARKET OVERVIEW 553
11.4 MARKET ANALYSIS AND FORECAST 558
11.4.1 Total Peripheral Intravenous Catheter Market 558
11.4.2 Conventional Peripheral Intravenous Catheter Market 566
11.4.3 Total Safety Peripheral Intravenous Catheter Market 573
11.4.3.1 Active Safety Peripheral Intravenous Catheter Market 580
11.4.3.2 Passive Safety Peripheral Intravenous Catheter Market 588
11.4.3.3 Integrated Blood Control Safety Peripheral Intravenous Catheter Market 595
11.4.4 Total Midline Catheter Market 602
11.4.4.1 Conventional Midline Catheter Market 604
11.4.4.2 Power-Injectable Midline Catheter Market 606
11.4.4.3 All-In-One Midline Catheter Market 608
11.5 DRIVERS AND LIMITERS 610
11.5.1 Market Drivers 610
11.5.2 Market Limiters 612
11.6 COMPETITIVE MARKET SHARE ANALYSIS 615
DIALYSIS CATHETER MARKET 619
12.1 INTRODUCTION 619
12.1.1 Hemodialysis Catheters 619
12.1.2 Acute Hemodialysis Catheters 620
12.1.3 Chronic Hemodialysis Catheters 620
12.1.4 Peritoneal Dialysis 621
12.1.5 AV Fistulae 621
12.1.6 AV Grafts 622
12.2 MARKET OVERVIEW 623
12.3 MARKET ANALYSIS AND FORECAST 627
12.3.1 Total Dialysis Catheter Market 627
12.3.2 Acute Hemodialysis Catheter Market 635
12.3.3 Total Chronic Hemodialysis Catheter Market 643
12.3.3.1 Conventional Chronic Hemodialysis Catheter Market 651
12.3.3.2 Antimicrobial Chronic Hemodialysis Catheter Market 658
12.3.4 Peritoneal Dialysis Catheter Market 666
12.4 DRIVERS AND LIMITERS 669
12.4.1 Market Drivers 669
12.4.2 Market Limiters 669
12.5 COMPETITIVE MARKET SHARE ANALYSIS 671
CATHETER SECUREMENT DEVICE MARKET 682
13.1 INTRODUCTION 682
13.1.1 Catheter Stabilization Methods 683
13.1.1.1 Tape and Dressings 683
13.1.1.2 Manufactured Catheter Securement Devices 683
13.1.1.3 Sutures 684
13.2 MARKET ANALYSIS AND FORECAST 685
13.3 DRIVERS AND LIMITERS 694
13.3.1 Market Drivers 694
13.3.2 Market Limiters 694
13.4 COMPETITIVE MARKET SHARE ANALYSIS 696
SYRINGE AND NEEDLE MARKET 700
14.1 INTRODUCTION 700
14.1.1 Two-Part and Three-Part Syringes 701
14.1.2 Safety Devices 701
14.1.3 Insulin Syringes 702
14.2 MARKET OVERVIEW 703
14.3 MARKET ANALYSIS AND FORECAST 707
14.3.1 Total Syringe and Needle Market 707
14.3.2 Total Syringe Market 715
14.3.2.1 Total Conventional Syringe Market 723
14.3.2.1.1 Two-Part Conventional Syringe Market 731
14.3.2.1.2 Three-Part Conventional Syringe Market 739
14.3.2.2 Safety Syringe Market 747
14.3.2.3 Total Insulin Syringe Market 755
14.3.2.3.1 Insulin Syringe with Needle Market 763
14.3.2.3.2 Insulin Syringe without Needle Market 765
14.3.3 Total Needle Market 767
14.3.3.1 Conventional Needle Market 775
14.3.3.2 Safety Needle Market 783
14.3.3.3 Blunt Type Needle Market 791
14.4 DRIVERS AND LIMITERS 793
14.4.1 Market Drivers 793
14.4.2 Market Limiters 794
14.5 COMPETITIVE MARKET SHARE ANALYSIS 797
APPENDIX I: VASCULAR ACCESS ULTRASOUND MARKET 803
15.1 MARKET ANALYSIS AND FORECAST 803
15.1.1 Vascular Access Ultrasound System Market 803
15.1.2 Tip-Placement System and Accessories Market 807
ABBREVIATIONS 809
The "European Market Report Suite for Vascular Access Devices and Accessories 2017 - MedSuite" includes analysis on the following companies currently active in this market: 3DT Holdings LLC 3M Access Scientific Ambu Inc. AngioDynamics Artsana B. Braun Baxter International Becton Dickinson Bionic C. R. Bard Cardinal Health CareFusion Codan Cook Medical Covidien Deltamed Districlass Medical Edwards Lifesciences Endeavor Capital Fresenius Grupo Sendal Interrad Medical Investindustrial Ivera Medical Corporation Joline Kimal LPI Medcomp Medikit Medtronic Navilyst Medical Nipro Medical Nostix, LLC Novico Pentaferte Perouse Medical PFM Medical PFM Medical PositiveID Corp. Rays Romedex Roundtable Healthcare Safety Syringes Inc. Semprus BioSciences Smiths Medical SonoSite, Inc. Teleflex Medical Terumo Troge Vascular Pathways, Inc. VeriTeQ Acquisition Corp. VigMed V-Tech Vygon *Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.
Chart 1 1: Vascular Access Device and Accessories Market by Segment, Europe, 2013 – 2023 2
Chart 1 2: Vascular Access Device and Accessories Market Overview, Europe, 2016 & 2023 2
Chart 3 1: Male Incidence, Digestive Cancer, U.S., 2016 34
Chart 3 2: Male Deaths, Digestive Cancer, U.S., 2016 34
Chart 3 3: Female Incidence, Digestive Cancer, U.S., 2016 35
Chart 3 4: Female Deaths, Digestive Cancer, U.S., 2016 35
Chart 3 5: Male Incidence, Genital Cancer, U.S., 2016 37
Chart 3 6: Male Deaths, Genital Cancer, U.S., 2016 37
Chart 3 7: Female Incidence, Genital Cancer, U.S., 2016 38
Chart 3 8: Female Deaths, Genital Cancer, U.S., 2016 38
Chart 3 9: Incidence by Gender, Breast Cancer, U.S., 2016 40
Chart 3 10: Deaths by Gender, Breast Cancer, U.S., 2016 40
Chart 3 11: Male Incidence, Respiratory Cancer, U.S., 2016 42
Chart 3 12: Male Deaths, Respiratory Cancer, U.S., 2016 42
Chart 3 13: Female Incidence, Respiratory Cancer, U.S., 2016 43
Chart 3 14: Female Deaths, Respiratory Cancer, U.S., 2016 43
Chart 3 15: Male Incidence, Urinary Cancer, U.S., 2016 45
Chart 3 16: Male Deaths, Urinary Cancer, U.S., 2016 45
Chart 3 17: Female Incidence, Urinary Cancer, U.S., 2016 46
Chart 3 18: Female Deaths, Urinary Cancer, U.S., 2016 46
Chart 3 19: Male Incidence, Skin Cancer, U.S., 2016 48
Chart 3 20: Male Deaths, Skin Cancer, U.S., 2016 48
Chart 3 21: Female Incidence, Skin Cancer, U.S., 2016 49
Chart 3 22: Female Deaths, Skin Cancer, U.S., 2016 49
Chart 3 23: Male Incidence, Lymphoma Cancer, U.S., 2016 51
Chart 3 24: Male Deaths, Lymphoma Cancer, U.S., 2016 51
Chart 3 25: Female Incidence, Lymphoma Cancer, U.S., 2016 52
Chart 3 26: Female Deaths, Lymphoma Cancer, U.S., 2016 52
Chart 3 27: Male Incidence, Endocrine Cancer, U.S., 2016 54
Chart 3 28: Male Deaths, Endocrine Cancer, U.S., 2016 54
Chart 3 29: Female Incidence, Endocrine Cancer, U.S., 2016 55
Chart 3 30: Female Deaths, Endocrine Cancer, U.S., 2016 55
Chart 3 31: Male Incidence, Leukemia Cancer, U.S., 2016 57
Chart 3 32: Male Deaths, Leukemia Cancer, U.S., 2016 57
Chart 3 33: Female Incidence, Leukemia Cancer, U.S., 2016 58
Chart 3 34: Female Deaths, Leukemia Cancer, U.S., 2016 58
Chart 3 35: Male Incidence, Oral Cavity/Larynx Cancer, U.S., 2016 60
Chart 3 36: Male Deaths, Oral Cavity/Larynx Cancer, U.S., 2016 60
Chart 3 37: Female Incidence, Oral Cavity/Larynx Cancer, U.S., 2016 61
Chart 3 38: Female Deaths, Oral Cavity/Larynx Cancer, U.S., 2016 61
Chart 3 39: Incidence by Gender, Myeloma Cancer, U.S., 2016 63
Chart 3 40: Deaths by Gender, Myeloma Cancer, U.S., 2016 63
Chart 3 41: Incidence by Gender, Brain/Other Nervous System Cancer, U.S., 2016 65
Chart 3 42: Deaths by Gender, Brain/Other Nervous System Cancer, U.S., 2016 65
Chart 3 43: Incidence by Gender, Soft Tissue Cancer, U.S., 2016 67
Chart 3 44: Deaths by Gender, Soft Tissue Cancer, U.S., 2016 67
Chart 3 45: Incidence by Gender, Bone and Joint Cancers, U.S., 2016 69
Chart 3 46: Deaths by Gender, Bone and Joint Cancers, U.S., 2016 69
Chart 3 47: Incidence by Gender, Eye and Orbit Cancers, U.S., 2016 71
Chart 3 48: Deaths by Gender, Eye and Orbit Cancers, U.S., 2016 71
Chart 3 49: End-Stage Renal Disease Incident Cases, U.S., 1996 – 2015 74
Chart 3 50: End-Stage Renal Disease Incident Cases by Modality, U.S., 1996 – 2015 76
Chart 3 51: End-Stage Renal Disease Incident Cases by Age Group, U.S., 1996 – 2015 78
Chart 3 52: End-Stage Renal Disease Incident Cases Using Home Dialysis by Therapy, U.S., 1996 – 2015 80
Chart 3 53: Vascular Access Use at Hemodialysis Initiation, U.S., 2005 – 2015 82
Chart 3 54: Vascular Access Use During First Year of Hemodialysis, U.S., 2013 – 2014 83
Chart 3 55: End-Stage Renal Disease Prevalent Case Count, U.S., 1996 – 2015 87
Chart 3 56: End-Stage Renal Disease Prevalent Cases by Modality, U.S., 1996 – 2015 89
Chart 3 57: Prevalent Hemodialysis Patients by Vascular Access Type, U.S., 2003 – 2015 91
Chart 3 58: End-Stage Renal Disease Prevalent Cases by Age Group, U.S., 1996 – 2015 93
Chart 3 59: End-Stage Renal Disease Prevalent Cases Using Home Dialysis by Therapy, U.S., 1996 – 2015 96
Chart 3 60: Diagnosed Diabetes Incidence Count Adults, U.S., 1997 – 2015 99
Chart 3 61: Diagnosed Diabetes Prevalence Count Adults, U.S., 1997 – 2015 104
Chart 4 1: Central Venous Catheter Market Segments, 2015 123
Chart 2 1: Vascular Access Device and Accessories Market by Segment, Europe, 2013 – 2023 284
Chart 2 2: Vascular Access Device and Accessories Market Breakdown, Europe, 2016 285
Chart 2 3: Vascular Access Device and Accessories Market Breakdown, Europe, 2023 285
Chart 2 4: Growth Rates by Segment, Vascular Access Device and Accessories Market, Europe, 2013 – 2023 288
Chart 2 5: Leading Competitors, Vascular Access Device and Accessories Market, Europe, 2016 296
Chart 3 1: Country Profile, Germany, 2016 318
Chart 3 2: Country Profile, France, 2016 319
Chart 3 3: Country Profile, United Kingdom, 2016 320
Chart 3 4: Country Profile, Italy, 2016 321
Chart 3 5: Country Profile, Spain, 2016 322
Chart 3 6: Country Profile, Benelux, 2016 323
Chart 3 7: Country Profile, Scandinavia, 2016 324
Chart 3 8: Country Profile, Austria, 2016 325
Chart 3 9: Country Profile, Switzerland, 2016 326
Chart 3 10: Country Profile, Portugal, 2016 327
Chart 4 1: Implantable Port Insertion Procedures, Europe, 2013 – 2023 333
Chart 4 2: Port Needle Insertion Procedures, Europe, 2013 – 2023 336
Chart 4 3: CVC Insertion Procedures, Europe, 2013 – 2023 339
Chart 4 4: PICC Insertion Procedures, Europe, 2013 – 2023 342
Chart 4 5: PIVC Insertion Procedures, Europe, 2013 – 2023 345
Chart 4 6: Dialysis Catheter Insertion Procedures by Type, Europe, 2013 – 2023 352
Chart 4 7: Ultrasound Vascular Access Procedures, Europe, 2016 354
Chart 5 1: Implantable Port Market by Segment, Europe, 2013 – 2023 360
Chart 5 2: Implantable Port Market Breakdown, Europe, 2016 361
Chart 5 3: Implantable Port Market Breakdown, Europe, 2023 361
Chart 5 4: Total Implantable Port Market, Europe, 2013 – 2023 364
Chart 5 5: Conventional Implantable Port Market, Europe, 2013 – 2023 371
Chart 5 6: Single-Lumen Conventional Implantable Port Market, Europe, 2013 – 2023 378
Chart 5 7: Double-Lumen Conventional Implantable Port Market, Europe, 2013 – 2023 380
Chart 5 8: Power-Injectable Implantable Port Market, Europe, 2013 – 2023 382
Chart 5 9: Single-Lumen Power-Injectable Implantable Port Market, Europe, 2013 – 2023 389
Chart 5 10: Double-Lumen Power-Injectable Implantable Port Market, Europe, 2013 – 2023 391
Chart 5 11: Leading Competitors, Implantable Port Market, Europe, 2016 400
Chart 6 1: Port Needle Market by Segment, Europe, 2013 – 2023 405
Chart 6 2: Port Needle Market Breakdown, Europe, 2016 406
Chart 6 3: Port Needle Market Breakdown, Europe, 2023 406
Chart 6 4: Total Port Needle Market, Europe, 2013 – 2023 409
Chart 6 5: Conventional Port Needle Market, Europe, 2013 – 2023 416
Chart 6 6: Safety Port Needle Market, Europe, 2013 – 2023 423
Chart 6 7: Power-Injectable Safety Port Needle Market, Europe, 2013 – 2023 430
Chart 6 8: Non-Power-Injectable Safety Port Needle Market, Europe, 2013 – 2023 437
Chart 6 9: Leading Competitors, Port Needle Market, Europe, 2016 448
Chart 7 1: Acute CVC Units Sold by Patient Type, Europe, 2016 455
Chart 7 2: Central Venous Catheter Market by Segment, Europe, 2013 – 2023 458
Chart 7 3: Central Venous Catheter Market Breakdown, Europe, 2016 459
Chart 7 4: Central Venous Catheter Market Breakdown, Europe, 2023 459
Chart 7 5: Total Central Venous Catheter Market, Europe, 2013 – 2023 462
Chart 7 6: Total Acute Central Venous Catheter Market, Europe, 2013 – 2023 469
Chart 7 7: Conventional Acute Central Venous Catheter Market, Europe, 2013 – 2023 476
Chart 7 8: Antimicrobial Acute Central Venous Catheter Market, Europe, 2013 – 2023 483
Chart 7 9: Chronic Central Venous Catheter Market, Europe, 2013 – 2023 490
Chart 7 10: Leading Competitors, Total Central Venous Catheter Market, Europe, 2016 503
Chart 7 11: Leading Competitors, Acute Central Venous Catheter Market, Europe, 2016 505
Chart 7 12: Leading Competitors, Chronic Central Venous Catheter Market, Europe, 2016 507
Chart 8 1: Peripherally Inserted Central Catheter Units Sold by Lumen Number, Europe, 2016 512
Chart 8 2: Peripherally Inserted Central Catheter Market by Segment, Europe, 2013 – 2023 515
Chart 8 3: Peripherally Inserted Central Catheter Market by Segment, Europe, 2016 516
Chart 8 4: Peripherally Inserted Central Catheter Market by Segment, Europe, 2023 516
Chart 8 5: Total Peripherally Inserted Central Catheter Market, Europe, 2013 – 2023 519
Chart 8 6: Conventional Peripherally Inserted Central Catheter Market, Europe, 2013 – 2023 526
Chart 8 7: Power-Injectable Peripherally Inserted Central Catheter Market, Europe, 2013 – 2023 533
Chart 8 8: Leading Competitors, Peripherally Inserted Central Catheter Market, Europe, 2016 547
Chart 9 1: Blood Control Safety Peripheral Intravenous Catheter Units Sold by Blood Control Mechanism, Europe, 2016 552
Chart 9 2: Peripheral Intravenous Catheter Market by Segment, Europe, 2013 – 2023 556
Chart 9 3: Peripheral Intravenous Catheter Market by Segment, Europe, 2016 557
Chart 9 4: Peripheral Intravenous Catheter Market by Segment, Europe, 2023 557
Chart 9 5: Total Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 560
Chart 9 6: Conventional Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 567
Chart 9 7: Total Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 574
Chart 9 8: Active Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 582
Chart 9 9: Passive Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 589
Chart 9 10: Integrated Blood Control Safety Intravenous Catheter Market, Europe, 2013 – 2023 596
Chart 9 11: Total Midline Catheter Market, Europe, 2013 – 2023 603
Chart 9 12: Conventional Midline Catheter Market, Europe, 2013 – 2023 605
Chart 9 13: Power-Injectable Midline Catheter Market, Europe, 2013 – 2023 607
Chart 9 14: All-In-One Midline Catheter Market, Europe, 2013 – 2023 609
Chart 9 15: Leading Competitors, Peripheral Intravenous Catheter Market, Europe, 2016 618
Chart 10 1: Dialysis Catheter Market by Segment, Europe, 2013 – 2023 625
Chart 10 2: Dialysis Catheter Market Breakdown, Europe, 2016 626
Chart 10 3: Dialysis Catheter Market Breakdown, Europe, 2023 626
Chart 10 4: Total Dialysis Catheter Market, Europe, 2013 – 2023 629
Chart 10 5: Acute Hemodialysis Catheter Market, Europe, 2013 – 2023 637
Chart 10 6: Total Chronic Hemodialysis Catheter Market, Europe, 2013 – 2023 645
Chart 10 7: Conventional Chronic Hemodialysis Catheter Market, Europe, 2013 – 2023 652
Chart 10 8: Antimicrobial Chronic Hemodialysis Catheter Market, Europe, 2013 – 2023 660
Chart 10 9: Peritoneal Dialysis Catheter Market, Europe, 2013 – 2023 668
Chart 10 10: Leading Competitors, Total Dialysis Catheter Market, Europe, 2016 676
Chart 10 11: Leading Competitors, Acute Hemodialysis Catheter Market, Europe, 2016 678
Chart 10 12: Leading Competitors, Chronic Hemodialysis Catheter Market, Europe, 2016 680
Chart 10 13: Leading Competitors, Peritoneal Dialysis Catheter Market, Europe, 2016 681
Chart 11 1: Catheter Securement Device Market, Europe, 2013 – 2023 688
Chart 11 2: Leading Competitors, Catheter Securement Device Market, Europe, 2016 699
Chart 12 1: Syringe and Needle Market by Segment, Europe, 2013 – 2023 705
Chart 12 2: Syringe and Needle Market by Segment, Europe, 2016 706
Chart 12 3: Syringe and Needle Market by Segment, Europe, 2023 706
Chart 12 4: Total Syringe and Needle Market, Europe, 2013 – 2023 709
Chart 12 5: Total Syringe Market, Europe, 2013 – 2023 717
Chart 12 6: Total Conventional Syringe Market, Europe, 2013 – 2023 725
Chart 12 7: Two-Part Conventional Syringe Market, Europe, 2013 – 2023 733
Chart 12 8: Three-Part Conventional Syringe Market, Europe, 2013 – 2023 741
Chart 12 9: Safety Syringe Market, Europe, 2013 – 2023 749
Chart 12 10: Total Insulin Syringe Market, Europe, 2013 – 2023 757
Chart 12 11: Insulin Syringe with Needle Market, Europe, 2013 – 2023 764
Chart 12 12: Insulin Syringe without Needle Market, Europe, 2013 – 2023 766
Chart 12 13: Total Needle Market, Europe, 2013 – 2023 769
Chart 12 14: Conventional Needle Market, Europe, 2013 – 2023 777
Chart 12 15: Safety Needle Market, Europe, 2013 – 2023 785
Chart 12 16: Blunt Type Needle Market, Europe, 2013 – 2023 792
Chart 12 17: Leading Competitors, Syringe and Needle Market, Europe, 2016 802
Chart 13 1: Ultrasound Vascular Access Device Market, Europe, 2013 – 2023 806

For a full figure list, please contact iData Research.

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Not Exactly What You Need?
close-link
close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link